Search result

Phantom 4 RTK/feed/category/dji-mavic-3e-pl- Page 159

AI Stocks Today (Dec. 22, 2025): Nvidia’s China Chip Pivot, Micron’s Memory Squeeze, and 2026 Forecasts Driving the AI Trade

AI Stocks Today (Dec. 22, 2025): Nvidia’s China Chip Pivot, Micron’s Memory Squeeze, and 2026 Forecasts Driving the AI Trade

Nvidia plans to begin shipping H200 AI chips to China by mid-February, pending Beijing approval, after the U.S. reversed restrictions and imposed a 25% fee. AI chip stocks led U.S. markets higher Monday morning, with Nvidia up 1.37% and Micron up 2.18%. Broader tech indexes also rose. Trading volume is expected to be lighter ahead of the Christmas holiday.
Costco Stock Forecast 2026: Latest COST News, Earnings Outlook, and Analyst Price Targets (Dec. 22, 2025)

Costco Stock Forecast 2026: Latest COST News, Earnings Outlook, and Analyst Price Targets (Dec. 22, 2025)

Costco reported Q1 fiscal 2026 net sales of $65.98 billion, up 8% year over year, and net income of $2.001 billion. Shares traded near $851 on Dec. 22, down 0.5% amid a December pullback. EPS of $4.50 beat Wall Street estimates. Membership renewal trends and tariff risks remain in focus following a rare “Sell” call from Roth Capital.
Netflix Stock (NFLX) Today: $25 Billion Financing, Warner Bros. Bid Battle, and Fresh Analyst Forecasts (Dec. 22, 2025)

Netflix Stock (NFLX) Today: $25 Billion Financing, Warner Bros. Bid Battle, and Fresh Analyst Forecasts (Dec. 22, 2025)

Netflix shares traded at $93.57 as of 15:37 UTC, down 0.9%, after the company refinanced part of its $59 billion bridge loan for the proposed Warner Bros. Discovery deal. The new structure includes a $5 billion revolving credit facility and $20 billion in term loans. Paramount Skydance renewed its challenge, backed by a personal guarantee from Oracle co-founder Larry Ellison.
Tesla Stock (TSLA) News Today (Dec. 22, 2025): Musk Pay Package Ruling, Robotaxi Momentum, Analyst Forecasts, and the Key Risks Ahead

Tesla Stock (TSLA) News Today (Dec. 22, 2025): Musk Pay Package Ruling, Robotaxi Momentum, Analyst Forecasts, and the Key Risks Ahead

Tesla shares hit an intraday high of $498.70 on December 22, 2025, after the Delaware Supreme Court restored Elon Musk’s 2018 compensation plan, now valued at about $139 billion. TSLA traded at $487.66, up 1.34% as of 15:14 UTC, amid renewed attention to Tesla’s robotaxi testing and ongoing legal and regulatory scrutiny.
22 december 2025
Applied Optoelectronics (AAOI) Stock Jumps on 800G Hyperscaler Momentum: Dec. 22, 2025 News, Analyst Forecasts, and Outlook

Applied Optoelectronics (AAOI) Stock Jumps on 800G Hyperscaler Momentum: Dec. 22, 2025 News, Analyst Forecasts, and Outlook

Applied Optoelectronics shares jumped 14% to 16% intraday Monday, trading near $36, after news of its first volume order for 800G data center transceivers from a major hyperscale customer. The company expects 800G shipments to add $4 million to $8 million in Q4 revenue. AAOI also reported $22 million in 400G orders year-to-date.
Home Depot (HD) Stock Today: Latest News, Analyst Forecasts, and the 2026 Outlook Investors Are Pricing In (Dec. 22, 2025)

Home Depot (HD) Stock Today: Latest News, Analyst Forecasts, and the 2026 Outlook Investors Are Pricing In (Dec. 22, 2025)

Home Depot shares traded around $347 Monday afternoon, up 0.7% for the day, as investors weighed new analyst commentary and 2026 outlooks. Wolfe Research nudged its price target to $415 and reiterated an Outperform rating. The stock remains down about 10% to 11% year-to-date, lagging the broader market. Trading volume and price range stayed steady, with no major corporate news.
22 december 2025
BioMarin (BMRN) Stock News Today: Amicus Acquisition Fallout, BMN 349 Cut, and Fresh Wall Street Price Targets (Dec. 22, 2025)

BioMarin (BMRN) Stock News Today: Amicus Acquisition Fallout, BMN 349 Cut, and Fresh Wall Street Price Targets (Dec. 22, 2025)

BioMarin shares fell 3.5% to $58.98 on Dec. 22 after analysts weighed in on its $4.8 billion Amicus Therapeutics acquisition and the company confirmed it ended development of BMN 349. Truist Securities raised its price target to $100, citing strategic fit, while other analysts questioned the deal’s impact on growth and balance sheet risk.
22 december 2025
Costco Stock (COST) After Hours Today, Dec. 22, 2025: Key Headlines, Analyst Calls, and What to Watch Before Tuesday’s Open

Costco Stock (COST) After Hours Today, Dec. 22, 2025: Key Headlines, Analyst Calls, and What to Watch Before Tuesday’s Open

Costco shares closed Monday at $850, down 0.66%, and slipped to $849.32 in late after-hours trading. The stock underperformed broader U.S. indexes, which rose as the VIX hit a year low. Guggenheim reiterated a Neutral rating, citing Costco’s high valuation and softening membership metrics. COST has fallen about 11% over six months, while the S&P 500 gained 12%.
23 december 2025
Warner Bros. Discovery (WBD) Stock After Hours Today (Dec. 22, 2025): Paramount’s Ellison-Backed $30 Bid vs. Netflix Deal — What to Know Before Tuesday’s Open

Warner Bros. Discovery (WBD) Stock After Hours Today (Dec. 22, 2025): Paramount’s Ellison-Backed $30 Bid vs. Netflix Deal — What to Know Before Tuesday’s Open

Warner Bros. Discovery shares rose 3.53% to $28.75 Monday after confirming receipt of an amended all-cash takeover bid from Paramount Skydance, backed by Larry Ellison’s $40.4 billion personal guarantee. The board said it still supports a rival Netflix deal and urged shareholders to take no action for now.
Lululemon Stock After Hours Today (Dec. 22, 2025): LULU Holds Near $212—What to Know Before the Market Opens Dec. 23

Lululemon Stock After Hours Today (Dec. 22, 2025): LULU Holds Near $212—What to Know Before the Market Opens Dec. 23

Lululemon shares closed Monday up 1.39% at $212.37, holding steady in after-hours trading. The stock remains about 50% below its 52-week high. Investors are watching a CEO transition, with Calvin McDonald set to step down and activist Elliott Management building a $1 billion stake. Trading volume was slightly below average.
FDA Approves Wegovy Pill: Novo Nordisk’s Oral Semaglutide Launch Ignites a 2026 Weight‑Loss Drug Showdown

FDA Approves Wegovy Pill: Novo Nordisk’s Oral Semaglutide Launch Ignites a 2026 Weight‑Loss Drug Showdown

The FDA approved Novo Nordisk’s once-daily Wegovy pill (oral semaglutide 25 mg) for chronic weight management and reducing cardiovascular risk in adults with obesity or overweight on December 22, 2025. The company plans a U.S. launch in January 2026 at $149 per month for eligible patients. Clinical trials showed average weight loss of 13.6% to 16.6% depending on adherence.
23 december 2025
Glencore plc Stock News and Forecast (GLEN.L): Share Price Holds Near 390p as Copper, Cobalt and Deal-Making Shape the 2026 Outlook

Glencore plc Stock News and Forecast (GLEN.L): Share Price Holds Near 390p as Copper, Cobalt and Deal-Making Shape the 2026 Outlook

Glencore shares traded at 389p in London on 23 December, near their 52-week high of 398.80p. The company agreed to acquire a majority stake in Dutch fuel supplier FincoEnergies, aiming to expand in Northwest Europe’s fuel and biofuels markets. The deal awaits EU antitrust approval and is expected to close in Q2 2026. Glencore also outlined plans to boost copper production to 1 million tonnes by 2028.
Novo Nordisk (NVO) Stock Jumps After FDA Approves Wegovy Pill: Today’s News, Analyst Forecasts, and 2026 Catalysts (23 December 2025)

Novo Nordisk (NVO) Stock Jumps After FDA Approves Wegovy Pill: Today’s News, Analyst Forecasts, and 2026 Catalysts (23 December 2025)

The FDA approved Novo Nordisk’s oral Wegovy pill for chronic weight management in the U.S., marking the first oral GLP-1 agonist cleared for this use. Shares jumped on the news, lifting European healthcare stocks. The company reported 16.6% mean weight loss in trials when taken as prescribed. Novo plans to launch the pill in the U.S. in early January 2026.
IonQ Stock (IONQ) Surges as Wall Street Turns Bullish: Today’s News, Analyst Price Targets, and the 2026 Outlook (Dec. 23, 2025)

IonQ Stock (IONQ) Surges as Wall Street Turns Bullish: Today’s News, Analyst Price Targets, and the 2026 Outlook (Dec. 23, 2025)

IonQ shares jumped 11.1% to close at $53.86 on Dec. 22, with trading volume near 28.6 million. The surge followed a series of positive analyst initiations, including Jefferies (Buy, $100 target), Wedbush (Outperform, $60), and Mizuho (Outperform, $90). Major firms like JPMorgan and Evercore ISI also launched coverage, fueling renewed interest and volatility in quantum stocks.
23 december 2025
1 157 158 159 160 161 176
Go toTop